HSAT prior to clinical sleep study for Sleep Apnea, Obstructive

Phase-Based Progress Estimates
Children's Hospital of Philadelphia, Philadelphia, PA
Sleep Apnea, Obstructive+7 More
Home sleep apnea test - DiagnosticTest
< 18
All Sexes
What conditions do you have?

Study Summary

This clinical trial will compare the diagnostic accuracy of type II HSAT with PSG for determining OSA status following treatment with adenotonsillectomy in children

Eligible Conditions

  • Sleep Apnea, Obstructive
  • Sleep disorders and disturbances
  • Sleep Disturbance
  • Sleep Apnea Syndromes

Treatment Effectiveness

Effectiveness Progress

1 of 3

Other trials for Sleep Apnea, Obstructive

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: up to one month

up to one month
Child-reported preference between HSAT and PSG
Correlation between OAHI from HSAT and score from OSA questionnaires
Correlation between obstructive apnea hypopnea index (OAHI) by HSAT vs PSG
Parent-reported preference between HSAT and PSG
up to one month.
Parent-reported acceptability of HSAT

Trial Safety

Safety Progress

1 of 3

Other trials for Sleep Apnea, Obstructive

Trial Design

2 Treatment Groups

PSG first Participants will be random
1 of 2
HSAT prior to clinical sleep study
1 of 2
Active Control
Experimental Treatment

60 Total Participants · 2 Treatment Groups

Primary Treatment: HSAT prior to clinical sleep study · No Placebo Group · N/A

HSAT prior to clinical sleep study
Experimental Group · 1 Intervention: Home sleep apnea test · Intervention Types: DiagnosticTest
PSG first Participants will be random
ActiveComparator Group · 1 Intervention: PSG · Intervention Types: DiagnosticTest

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to one month
Closest Location: Children's Hospital of Philadelphia · Philadelphia, PA
Photo of Philadelphia  1Photo of Philadelphia  2Photo of Philadelphia  3
2011First Recorded Clinical Trial
8 TrialsResearching Sleep Apnea, Obstructive
659 CompletedClinical Trials

Eligibility Criteria

Age < 18 · All Participants · 2 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are a male or female child between the ages of 5 and 12 years old.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.